The utilization of the analysis found that WNT5A expression was significantly upregulated in eight cancers shown by GEPIA databases. These cancers include glioblastoma multiforme (GBM), kidney renal papillary cell carcinoma brain (KIRP), lower grade glioma (LGG), LUSC, pancreatic adenocarcinoma (PAAD), rectum adenocarcinoma (READ), stomach adenocarcinoma (STAD), and thymoma (THYM). Moreover, the expression of WNT5A significantly increased in two types of cancer (LUSC and STAD) compared to normal samples (Figure 1C). This evidence concerns the gene WNT5A and glioblastoma.